Home > Insider Trading > Filing (0001555280-23-000108)

Filing Details

Accession Number:: 0001555280-23-000108
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-02-16 16:18:49
Reporting Period:: 2023-02-14

Accepted Time:: 2023-02-16 16:18:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1555280	Zoetis Inc.	ZTS	Pharmaceutical Preparations (2834)	460696167

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1567878	Roxanne Lagano	C/O Zoetis Inc. 10 Sylvan Way Parsippany NJ 07054	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-02-14	6,984	$73.24	33,341	No	4	M	Direct
Common Stock	Acquisiton	2023-02-14	6,026	$87.51	39,367	No	4	M	Direct
Common Stock	Disposition	2023-02-14	13,010	$175.00	26,357	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2023-02-14	6,984	$0.00	6,984	$0.00
Common Stock	Stock Option	Disposition	2023-02-14	6,026	$0.00	6,026	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
30,585			No	4	M	Direct
24,559			No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	796	Indirect	401(k)

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option	$162.07			6,542	6,542	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	6,542	6,542	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2022.
The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.
Represents the common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan, as of December 31, 2022.
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
6,984 options granted February 13, 2018 at an exercise price of $73.24 per option.
Each option vests on the third anniversary of the date of grant.
Each option expires on the tenth anniversary of the date of grant.
2,328 options granted February 13, 2018 at an exercise price of $73.24 per option; 8,036 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option.
6,026 options granted on February 12, 2019 at an exercise price of $87.51 per option.
2,328 options granted February 13, 2018 at an exercise price of $73.24 per option; 2,010 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option.
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
One-third of each option will vest on the first, second and third anniversaries of the date of grant.